Page last updated: 2024-08-24

bromfenac and Uveitis

bromfenac has been researched along with Uveitis in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, PQ; Jin, CF; Shentu, XC; Wang, QW; Weng, Y; Wu, W; Xie, X; Xu, W; Yao, K; Yu, YH; Zhang, L; Zhu, YN	1
Abu Al-Fadl, EM; Arcinue, CA; Artornsombudh, P; Foster, CS; Radwan, AE; Yang, P	1
Goldberg, DF; Gow, JA; Peace, JH; Walters, TR	1
Bucolo, C; Drago, F; Marrazzo, G; Platania, CB; Romano, GL; Salomone, S	1

Trials

2 trial(s) available for bromfenac and Uveitis

Article	Year
Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2013, Volume: 229, Issue:4 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Fluorometholone; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Treatment Outcome; Uveitis	2013
Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials. Ophthalmology, 2014, Volume: 121, Issue:1 Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Double-Blind Method; Eye Pain; Female; Humans; Inflammation; Lens Implantation, Intraocular; Male; Ophthalmic Solutions; Phacoemulsification; Postoperative Care; Prospective Studies; Treatment Outcome; Uveitis	2014

Article

Year

Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde, 2013, Volume: 229, Issue:4

Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Dexamethasone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluorescein Angiography; Fluorometholone; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Prospective Studies; Treatment Outcome; Uveitis

2013

Bromfenac ophthalmic solution 0.07% dosed once daily for cataract surgery: results of 2 randomized controlled trials.

Ophthalmology, 2014, Volume: 121, Issue:1

Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Double-Blind Method; Eye Pain; Female; Humans; Inflammation; Lens Implantation, Intraocular; Male; Ophthalmic Solutions; Phacoemulsification; Postoperative Care; Prospective Studies; Treatment Outcome; Uveitis

2014

Other Studies

2 other study(ies) available for bromfenac and Uveitis

Article	Year
Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:7 Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity	2013
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation. The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:7 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cyclooxygenase 2; Dinoprostone; Indomethacin; Inflammation; Lipopolysaccharides; Male; Phenylacetates; Rats, Sprague-Dawley; Retina; Retinal Hemorrhage; Uveitis	2014

Article

Year

Bromfenac alone or with single intravitreal injection of bevacizumab or triamcinolone acetonide for treatment of uveitic macular edema.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:7

Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Benzophenones; Bevacizumab; Bromobenzenes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Intravitreal Injections; Macular Edema; Male; Middle Aged; Ophthalmic Solutions; Retreatment; Retrospective Studies; Treatment Outcome; Triamcinolone Acetonide; Uveitis; Visual Acuity

2013

Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.

The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:7

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cyclooxygenase 2; Dinoprostone; Indomethacin; Inflammation; Lipopolysaccharides; Male; Phenylacetates; Rats, Sprague-Dawley; Retina; Retinal Hemorrhage; Uveitis

2014